Alere Triage® 97300EURecalls & reported problems
Alere San Diego, Inc. · Alere Triage® Profiler SOB™ Panel · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00899722002740), received between Apr 16, 2018 and Apr 16, 2018 — classified as 1 malfunction.
The most frequently reported specific device problem is “Low Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Low Test Results1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 16, 2018Low Test Results; Low Test Results
A PATIENT EXPERIENCED RESPIRATORY DISTRESS AND WAS TESTED FOR CARDIAC MARKERS USING THE TRIAGE SYSTEM. THE TRIAGE SYSTEM PRODUCED RESULTS OF TNI= <0.05 NG/ML AND BNP= 96 PG/ML. AS THE TRIAGE TNI RESULT WAS DETERMINED TO BE NORMAL BY THE CUSTOMER, THE PATIENT WAS TAKEN TO THE EMERGENCY UNIT OF A HOSPITAL INSTEAD OF A HOSPITAL WITH A CARDIOLOGY UNIT. THE PATIENT WAS TESTED IN THE EMERGENCY UNIT BY ANOTHER SERVICE AN HOUR LATER AND RECEIVED RESULTS OF TNI= 0.0792 NG/ML AND BNP= 387 PG/ML (NORMAL TNI CUTOFF FOR THIS INSTRUMENT= 0.034 NG/ML). AS THIS TNI RESULT WAS ABNORMAL, THE DECISION WAS MADE TO TRANSFER THE PATIENT TO ANOTHER HOSPITAL SPECIALIZED IN CARDIOLOGY. THE PATIENT'S DIAGNOSIS PRIOR TO TRANSFER WAS HEART FAILURE AND CORONARY DISTRESS. AS OF MARCH 29, 2018, THE PATIENT IS REPORTED TO BE IN GOOD CONDITION.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7434896 ↗
Other Test,Natriuretic Peptide devices
- PATHFAST NTproBNP N/APhc Corporation · Test,Natriuretic Peptide1 recall0 reports
- VITROS 6192255Ortho Clinical Diagnostics · Test, natriuretic peptide18 reports
- Elecsys proBNP II Immunoassay 09315284190Roche Diagnostics GmbH · Test, natriuretic peptide8 reports
- Elecsys proBNP II Immunoassay 09315268160Roche Diagnostics GmbH · Test, natriuretic peptide5 reports
- VITROS 6802156Ortho Clinical Diagnostics · TEST,NATRIURETIC PEPTIDE3 reports
- i-STAT 03P93-25Abbott Point Of Care Inc. · TEST,NATRIURETIC PEPTIDE2 reports
- Access BNP 98200Beckman Coulter, Inc. · Test, Natriuretic Peptide2 reports
- Elecsys proBNP II STAT Immunoassay 09315276160Roche Diagnostics GmbH · Test, natriuretic peptide2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page